Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland

Table 3 Visits for various gynecological reasons in primary and specialized care

Reason for visiting	Total number of visits	Visits per 100 woman-years (95% CI)
All gynecological reasons^a
LARC initiation	1346	39.8 (37.7–42.0)
SARC initiation or switch	1236	40.6 (38.3–42.9)
SARC continuation	1448	27.6 (26.2–29.0)
All	4030	34.5 (33.5–35.6)
Menstrual problems^a
LARC initiation	465	13.8 (12.5–15.1)
SARC initiation or switch	562	18.4 (16.9–20.0)
SARC continuation	493	9.4 (8.6–10.3)
All	1520	13.0 (12.4–13.7)
Vaginal infections (such as candida or bacterial vaginosis)^a
LARC initiation	294	8.7 (7.7–9.8)
SARC initiation or switch	288	9.4 (8.4–10.6)
SARC continuation	325	6.2 (5.5–6.9)
All	907	7.8 (7.3–8.3)
Visits for abortion care at family planning clinics or specialized health care
LARC initiation	42	1.2 (0.9–1.7)
SARC initiation or switch	476	15.6 (14.2–17.1)
SARC continuation	135	2.6 (2.2–3.0)
All	653	5.6 (5.2–6.0)
Diagnoses of STIs^b
LARC initiation	51	1.5 (1.1–2.0)
SARC initiation or switch	101	3.3 (2.7–4.0)
SARC continuation	109	2.1 (1.7–2.5)
All	261	2.2 (2.0–2.5)
Pelvic inflammatory disease diagnoses^a
LARC initiation	87	2.6 (2.1–3.2)
SARC initiation or switch	16	0.5 (0.3–0.9)
SARC continuation	28	0.5 (0.4–0.8)
All	131	1.1 (0.9–1.3)

LARC long-acting reversible contraception; SARC short-acting reversible contraception; CI confidence interval; STI sexually transmitted infection
^aIn primary or specialized health care
^bAccording to the register of infectious diseases, including chlamydia, gonorrhea, and syphilis

ISSN: 1471-2458